StockData
Aspire-Lakewood Holdings, Inc. logo

Aspire-Lakewood Holdings, Inc. (ASBP) stock

ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 2/30
$8.30+0.24 (+2.98%)

Close on Nov 17, 2026Market cap $11.64MP/E –Yield –

Aspire-Lakewood r&d expenses

Research and development expenses are spending on new products and technology.

Aspire-Lakewood's R&D Expenses for the twelve months ending Jun 30, 2026 was $838.14K, up 13.4% year over year. For fiscal 2025 it was $923.91K, up 540.0% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$923.91K+540.0%
FY2024Dec 31, 2024$144.36K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$233.48K-33.8%
Q1 FY2026Mar 31, 2026$296.72K+12.8%
Q4 FY2025Dec 31, 2025$100.04K-14.0%
Q3 FY2025Sep 30, 2025$207.90K+2870.0%
Q2 FY2025Jun 30, 2025$352.89K+3260.8%
Q1 FY2025Mar 31, 2025$263.09K+2405.6%
Q4 FY2024Dec 31, 2024$116.36K–
Q3 FY2024Sep 30, 2024$7.00K–
Q2 FY2024Jun 30, 2024$10.50K–
Q1 FY2024Mar 31, 2024$10.50K–

More Aspire-Lakewood figures

See a number that looks wrong?